Biomerics, a leading medical device manufacturer for the cardiovascular market, will relocate to a new 230,000 square foot corporate headquarters in Salt Lake City, Utah.

The company specializes in the design, development and production of medical devices for diagnostic and interventional procedures for the cardiovascular, structural heart, cardiac rhythm management and vascular access markets.

Biomerics expects to invest $38.5 million in the expansion over the next 8 years and to add over 380 new jobs. As an incentive, Utah Governor's Office of Economic Development provided up to $3 million in tax incentives for the investment.

The facility, located in the International Center west of the Salt Lake City International Airport, will include corporate offices, engineering offices, research and development labs, and cleanroom manufacturing.

"The team has done an excellent job designing a facility that reflects the vision and growth expectations of the company," stated Travis Sessions, CEO of Biomerics.

"This investment will support the next phase of the company's growth strategy and will expand our device design, development, and manufacturing capabilities." The headquarters is engineered to accommodate up to 600 employees and will include a full range of manufacturing technologies including implantable material polymerization, molding, extrusion, coating, and catheter assembly,” he added.

The location selection process, building design, and construction are being managed by Wasatch Commercial Management, Utah's leading commercial real estate development and management company.

"Wasatch specializes in partnering with companies like Biomerics," stated John Dahlstrom, Executive Vice President of Wasatch Commercial Management. "We are excited to work on a second facility with Biomerics. Our team and development processes enable clients to envision their future needs and develop space to achieve their goals." The completion of the facility, including commission and validation, is anticipated during the second quarter of 2018. Once complete the facility will accommodate managers, scientists, engineers, quality specialists, regulatory experts, and operators.